Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 395 participants.
Also called NCT07439133
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 395 participants
- Sponsor
- Sinotau Pharmaceutical Group
- Registry
-
NCT07439133
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07439133. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-11-14 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
- Intervention (Drug)
- XTR004
- Lead sponsor
- Sinotau Pharmaceutical Group
Record details
- Record id
cardio:ct-nct07439133- Content hash
6e6ece3fc6f3893774acd84d3e82dff4696b437cd0dd8a40af309aa7c58eb03e